Alizarin, which reduces ExoS, attenuates inflammation by P. aeruginosa in H292 cells
Journal of Microbiology · 2025
DOI: 10.71150/jm.2411012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology, 2025. Verfasst von Seung-Ho Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungbuk 28116, Republic of Korea. Hauptthemen laut MEDLINE: Anthraquinones, Pseudomonas aeruginosa, Bacterial Toxins, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Honam National Institute of Biological Resources, Ministry of Environment.
Abstract (Originalsprache)
Pseudomonas aeruginosa (P. aeruginosa) is resistant to several drugs as well as antibiotics and is thus classified as multidrug resistant and extensively drug resistant. These bacteria have a secretion system called the "type 3 secretion system (T3SS)", which facilitates infection by delivering an effector protein. ExoenzymeS (ExoS) is known to induce cell death and activate caspase-1. In particular, patients infected with P. aeruginosa develop diseases associated with high mortality, such as pneumonia, because no drug targets an ExoS or T3SS. We selected natural compounds to treat T3SS-mediated pneumonia and chose alizarin, a red dye. We confirmed the effects of alizarin on T3SS by bacterial PCR and ELISA. It was confirmed that alizarin regulates ExoS by inhibiting exsA but also popD and pscF. Furthermore, in infected H292 cells, it not only attenuates inflammation by inhibiting lipopolysaccharide (LPS)-induced phosphorylation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65 but also interferes with the level of ExoS delivered into the host and modulates caspase-1. We confirmed this result and determined that it led to decreases in proinflammatory cytokines such as Interleukin-1beta (IL-1β), Interleukin-6 (IL-6), and Interleukin-18 (IL-18). Therefore, we suggest that alizarin is a suitable drug for treating pneumonia caused by P. aeruginosa because it helps to attenuate inflammation by regulating T3SS and NF-κB signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungbuk 28116, Republic of Korea.
- College of Life Sciences and Biotechnology, Korea University, Seoul, 02841, Republic of Korea.
- Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
- AptaBio, Gyeonggi-do 16954, Republic of Korea.
- ELEO Inc., Daejeon 34141, Republic of Korea.
- Division of Practical Research, Honam National Institute of Biologucal Resources (HNIBR), Jeollanam-do 58762, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Honam National Institute of Biological Resources
- Ministry of Environment
- Korea Research Institute of Bioscience and Biotechnology
Zitieren
APA
Kim, S. H., Ahn, H. I., Oh, J. H., Seo, D. Y., Kim, J. H., Kwon, O. K., Park, J. W., & Ahn, K. S. (2025). Alizarin, which reduces ExoS, attenuates inflammation by P. aeruginosa in H292 cells. Journal of Microbiology. https://doi.org/10.71150/jm.2411012
Vancouver
Kim SH, Ahn HI, Oh JH, Seo DY, Kim JH, Kwon OK, et al. Alizarin, which reduces ExoS, attenuates inflammation by P. aeruginosa in H292 cells. Journal of Microbiology. 2025. doi:10.71150/jm.2411012
BibTeX
@article{Kim2025,
author = {Kim, Seung-Ho and Ahn, Hye In and Oh, Jae-Hoon and Seo, Da Yun and Kim, Jung-Hee and Kwon, Ok-Kyoung and Park, Ji-Won and Ahn, Kyung-Seop},
title = {Alizarin, which reduces ExoS, attenuates inflammation by P. aeruginosa in H292 cells},
journal = {Journal of Microbiology},
year = {2025},
doi = {10.71150/jm.2411012}
}
EUVIMED